DAs a pharmaceutical company Pfizer Has applied for emergency approval for its Covid-19 drug Paxlovid in the United States. As Pfizer announced on Tuesday (local time), the relevant documents have been submitted to the FDA. CEO Albert Bourla said that the drug’s “overwhelming effectiveness” in a recent study showed that oral antiviral therapy can play a decisive role in the fight against Covid-19 .
According to the company, since the beginning of November, Corona Pills have been very successful in preventing serious diseases in high-risk patients. According to Pfizer, an interim analysis of test results found that drug Pfizer said it will reduce the risk of hospitalization and death for Covid-19 patients by 89%. This applies to treatment within three days after the first Covid 19 symptoms appear; treatment within five days will also produce similar values.
The British Medicines Agency (MHRA) recently approved Lagevrio tablets (also known as molnupiravir). The European Medicines Agency (EMA) announced at the end of October that it would review the use of monopiravir.
